Articles tagged with Myocardial Infarction
A study led by researchers from Mount Sinai Hospital shows that a nanotherapeutic medicine can halt the growth of artery plaque cells and suppress inflammation, leading to reduced heart attack risk. The therapy uses high-density lipoprotein (HDL) to target inflamed immune cells in arterial plaques.
A Johns Hopkins report provides clinicians with concrete tips to help patients decide whether to take statins, balancing benefits and risks. The report emphasizes the importance of individualized advice, clear explanation of benefits and risks, and shared decision-making.
Researchers identified five familial cases of spontaneous coronary artery dissection (SCAD), a condition where a tear occurs inside an artery leading to a heart attack. The study suggests that SCAD may be inherited, with implications for at-risk family members and a better understanding of the condition.
A study published in The Lancet suggests that routine heart scans for patients referred to cardiac clinics with chest pain could reduce heart attack rates. The SCOT-HEART trial found that around a quarter of patients had their diagnoses reclassified after receiving the scan, prompting new treatments in many cases.
A large study has found that routine blood clot removal during heart attack treatment does not benefit patients and may increase the risk of stroke. The TOTAL trial involved over 10,700 patients and showed no differences in cardiovascular outcomes between those who received clot removal and those who did not.
A study found that complete revascularization after emergency angioplasty for STEMI reduced unplanned angioplasty or bypass surgery by 12%. Rates of death and repeat heart attacks were comparable between groups. The approach may help patients avoid future cardiac events.
A study of over 18,000 patients found that newer drug-coated stents have similar long-term rates of death as traditional bypass surgery. However, the stent group had slightly more heart attacks in the long term.
The study found that Bendavia did not prevent irreversible injury to the heart but showed a trend towards improved heart pumping function. The drug is well-tolerated but lacks significant benefits in reducing scarring from angioplasty after a heart attack.
Studies link energy drink consumption to increased resting blood pressure, while smoking is associated with a higher risk of fractured stents in limb arteries. Social habits also play a role in recovery from early-onset heart attacks in low-income urban communities.
The study found that adding ticagrelor to aspirin therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, with benefits appearing for nearly three years. The trial recruited 21,162 patients and showed a 15% reduction in cardiovascular death with both ticagrelor doses.
Research found that nearly 5,000 coronary heart disease patients experienced a significant increased risk of death or heart attack when experiencing high stress and heavy depressive symptoms. The 'psychosocial perfect storm' was validated by the study's findings, which suggest behavioral interventions could help manage both conditions.
A study published in Annals of Emergency Medicine found that physicians and patients significantly overestimated the risk of heart attack and death from acute coronary syndrome. Despite discussions about risk, patients' assessment of their risk remained unchanged or increased, highlighting ineffective patient-physician communication.
A study found that pre-hospital delays for women with heart attacks were associated with a higher risk of dying. Women waited an average of one hour to call emergency services and over 70% took longer than an hour to get to a hospital equipped to treat them.
Research suggests statin therapy provides greatest benefit to patients with highest genetic risk of heart attack. Genetic analysis assesses heart attack risk independently of traditional factors, identifying those at higher baseline risk who reap greater benefits from therapy. The study's findings have implications for precision medici...
Researchers identified a genetic risk score that predicts cardiovascular death and heart attack risk, with individuals in the highest genetic risk group experiencing a significant reduction in cardiovascular risk with statin therapy. The study found a three-fold increase in absolute risk reduction in those with high genetic risk.
A recent meta-analysis of 36 studies found that moderate coffee consumption is associated with a decreased risk of heart disease. Participants who consumed 3-5 cups of coffee per day had the lowest risk of clogged arteries and heart attacks.
A new study in JAMA found that patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) along with anticoagulant medications after a heart attack are at higher risk for bleeding and cardiovascular events. The research suggests that there is no safe window for concomitant NSAID use, even short-term treatment.
A recent study published in the European Heart Journal: Acute Cardiovascular Care found that intense anger is associated with a significantly higher risk of heart attack. The study discovered that acute coronary blockage was more likely to occur within two hours of an angry episode, with the risk being eight times higher than usual.
USF scientists found that statins produce a significant reduction in cholesterol levels but have failed to substantially improve cardiovascular outcomes. The researchers argue that advocates for statins have used statistical deception to inflate their effectiveness and downplay adverse effects.
Researchers at Columbia University Irving Medical Center developed nanoparticles that deliver a special type of healing molecule to fat deposits in arteries, slowly releasing the drug and repairing damage. The approach avoids common side effects and may prevent heart attacks by targeting inflammation hotspots.
A study found that older adults with physical limitations who engage in low-intensity activities for a short duration can lower their risk of heart attack and coronary death. Participants who spent more time being sedentary had higher predicted risks, highlighting the importance of regular intervals of movement.
Patients receiving fondaparinux had a lower risk of major bleeding events and death following a heart attack compared to those receiving low-molecular-weight heparin. This association was observed in both hospital settings and six months post-incident.
A new study by Johns Hopkins Medicine reveals that four out of five widely used clinical calculators significantly overestimate the likelihood of a heart attack. The researchers found that these algorithms calculate heart attack probability using factors such as gender, age, smoking history, and cholesterol levels, but may not accurate...
Research presented at the Saudi Heart Association conference reveals that 26% of participants are at high risk of having a heart attack or dying from a heart attack in 10 years. The study found that diabetes, obesity, and smoking were major contributors to this risk.
A new study found that young and middle-aged women experience higher levels of mental stress after a heart attack, leading to worse recovery outcomes. The study analyzed data from over 2,400 female and male heart attack survivors between 18-55 years old.
Two genetic mutations on a single gene have been found to interact and lower the risk of heart attacks in people who carry both variants. The study suggests that clinicians should test individuals with reduced activity of DBH and norepinephrine to determine if they benefit from beta blockers.
Researchers at Oregon Health & Sciences University successfully tested a peptide developed by Case Western Reserve neurosciences professor Jerry Silver, PhD, which showed 100% success in animal models, regenerating nerves into heart attack scar tissue and preventing arrhythmia.
A recent study published in Clinical Infectious Diseases found that the adjusted risk ratio for heart attacks among HIV-positive patients decreased from an 80% increased risk in 1996 to no increased risk in 2010-2011. The improved care and treatments led by Kaiser Permanente's early awareness of cardiovascular disease risks have result...
Researchers at NYU Polytechnic School of Engineering have developed a new colloidal gold test strip that demonstrates high detection sensitivity for cardiac troponin I (cTn-I) detection. The new strip uses microplasma-generated gold nanoparticles, attracting more antibodies and resulting in significantly higher detection sensitivity.
A new study found that long-term exposure to terrorism threat increases resting heart rates and mortality risk in Israelis. The study, conducted on 17,300 healthy subjects, reveals a link between fear of terror and elevated heart rates.
A new study found that most heart attack patients do not receive sexual counseling from their healthcare provider, with only 12% of women and 19% of men reporting such advice. The researchers recommend that healthcare providers raise the issue of resuming sexual activity with their patients, as it is an important aspect of overall health.
A study found that racial and ethnic disparities in acute care narrowed significantly as hospitals improved quality, with nine major disparities mostly disappearing by the end of 2010. Hospitals serving minorities made faster improvements and delivered more equal care to white and minority patients over time.
Researchers at Imperial College London discovered a possible way to identify which patients should avoid using COX-2 inhibitors, a type of non-steroidal anti-inflammatory drug (NSAID), due to increased heart attack risk. The study found that COX-2 inhibitors raise levels of ADMA, an independent risk factor for cardiovascular disease.
Researchers identified rare APOA5 gene mutations linked to high triglycerides and increased heart attack risk. The study found that these mutations also raise LDL receptor mutation prevalence, underscoring the role of triglyceride metabolism in early-onset heart attacks.
Research suggests that patients with erectile dysfunction who follow a Mediterranean diet have less vascular and cardiac damage, reducing their risk of heart attack and stroke. A lower Med-Diet Score correlated with worse vascular and heart function, including increased intima-media thickness and aortic stiffness.
Physician-researcher Sumeet Chugh receives $2.36 million grant to develop prevention strategies for sudden cardiac arrest. The study focuses on patients aged 35-59 years old and aims to identify risk factors, including sex hormones and genetics.
A Vanderbilt University study found a nationwide decline of 30% in ST-elevation myocardial infarction (STEMI) patients between 2006-2011. This decrease may lead to reduced experience among emergency doctors, potentially affecting the timeliness and quality of care for time-sensitive heart attacks.
A new study analyzes individual results and population-level data to clear the paradox of faster heart attack treatment times. The findings show that treating more complex patients with emergency angioplasty and stents appears to be why mortality hasn't decreased with reduced door-to-balloon time.
A new study by researchers from the University of Sheffield confirms that treating heart attack patients with ticagrelor reduces the risk of stents blocking with blood clots, which can be fatal. The study found that this pioneering drug could halve the risks of stent blockage compared to previous standard treatment clopidogrel.
A new trans-satellite wireless 12-lead ECG has been shown to significantly reduce treatment time for people with severe heart attacks. The study found that patients who received a wireless ECG had a hospital arrival to angioplasty time of 53 minutes, compared to 104 minutes for those who did not receive the test.
A new study by Intermountain Medical Center found that routine heart imaging screenings for diabetic patients at high risk of heart disease did not prevent heart attacks, hospitalization, or cardiac death. High-quality diabetes management remains the most effective way to avoid these events.
A randomized trial of 900 patients with diabetes found no benefit from routine CT angiography screening for coronary artery disease (CAD) in reducing mortality, heart attacks, or hospitalizations. The study suggests that guideline-directed medical therapy for hypertension and hyperlipidemia is effective in asymptomatic patients with di...
Researchers at Cedars-Sinai Medical Center have found that injections of cardiac stem cells may help reverse heart damage caused by Duchenne muscular dystrophy, potentially leading to improved heart function and exercise capacity. The study involved laboratory mice infused with cardiac stem cells, which showed marked improvement in hea...
Researchers used big data analysis to identify crizotinib, a cancer drug, as a possible candidate for a new stent coating. The medication helped prevent stent disease and protected the endothelium without affecting blood vessel lining in mice.
Researchers found no significant reduction in cardiovascular events, but a lower incidence of nonfatal heart attack and transient ischemic attack. Aspirin increased the risk of extracranial hemorrhage requiring hospitalization.
A new study by Mount Sinai Heart and CNIC in Spain reveals two waves of heart muscle inflammation after a heart attack, contradicting previous consensus. The researchers discovered the first wave occurs immediately after the attack and subsides, followed by a second wave that arises a week later.
Research at Mayo Clinic reveals that patients with active asthma are at a twofold risk of having a heart attack. Patients with inactive asthma were not found to be at an increased risk, highlighting the need for better control of asthma symptoms and medication use.
A recent study by Duke University researchers found that over half of STEMI heart attack patients had one or both of their other arteries obstructed, leading to worse outcomes. The study suggests that opening all blocked arteries may become a standard procedure.
Research studies presented at the American Heart Association's Scientific Sessions 2014 found that people with active asthma are more likely to experience a heart attack. Participants in the Multi-Ethnic Study of Atherosclerosis (MESA) who required daily medications for asthma were 60% more likely to have a cardiovascular event.
The DAPT Study found that continuing dual antiplatelet therapy for at least 30 months significantly reduced the risk of stent thrombosis and major adverse cardiovascular events. This benefit was observed across all stent types and patient characteristics, with a notable reduction in heart attack risk.
A new study published in JAMA found that hospitalized patients with STEMI heart attacks are more likely to die than those who had the same type of heart attack outside the hospital. The study analyzed data from over 62,000 patients and found that these patients were older, female, and less likely to receive routine treatments for STEMI.
Patients who develop heart attacks in hospitals for non-acute conditions have a 3.5-fold higher mortality rate compared to those with outpatient-onset STEMI. Inpatient-onset STEMI patients are also less likely to be discharged home and undergo necessary treatments, leading to longer hospital stays and higher costs.
Researchers at Sentient Science and University at Buffalo develop wearable technology to measure stress, fatigue, and resilience. The system sends personalized alerts to prevent heart attacks and physical injuries.
A new study found that survivors of heart attacks and strokes experience a rapid decline in physical abilities over time, leading to increased disability and depressive symptoms. The study suggests that these survivors should be screened for functional disability long after discharge from the hospital.
A new study published in PLOS ONE suggests that a dose of iodide can significantly reduce the damage caused by reperfusion injury after a heart attack. The study found that intravenous infusions of sodium iodide reduced myocardial infarction damage by up to 75 percent in mice, and oral iodide showed similar protective effects.
A study of nearly 38,000 patients found that those diagnosed with nonobstructive coronary artery disease (CAD) had a significantly increased risk of heart attack or death one year after diagnosis. Patients with nonobstructive CAD had an associated risk of MI that was 2-to 4.5-fold greater than among those with no apparent CAD.
A recent study highlights the dangers of women delaying medical attention for heart symptoms, citing a higher likelihood of severe or advanced stage treatment options being limited. Women often attribute symptoms to other possibilities and exhibit an optimistic bias, waiting longer to seek care than men.
A clinical study found that high levels of TMAO, a chemical byproduct of intestinal bacteria digestion, are linked to an increased risk of heart failure and poor long-term prognosis. Patients with low TMAO levels had a lower mortality rate despite advanced heart failure symptoms.
A new study by researchers at Intermountain Medical Center Heart Institute suggests that lifestyle choices, not just genetics, may contribute to the risk of heart attack. The study found that severe coronary artery disease can be inherited, but the presence of heart attacks in people with less severe disease was not clustered in families.
According to research presented at Acute Cardiovascular Care 2014, nearly one quarter of patients in the study were depressed and nearly a quarter had received treatment for depression. Women were more likely to develop anxiety and depression after a heart attack compared to men, with current smokers also showing higher levels of anxiety.